Is widespread screening for hepatitis C justified? Several organisations have recommended greatly expanded screening for hepatitis C infection. Ronald Koretz and colleagues are concerned that no study has tested whether this will lead to net clinical benefit or harm in screened populations

Ronald L. Koretz, Kenneth W. Lin, John P.A. Ioannidis, Jeanne Lenzer

Research output: Contribution to journalArticlepeer-review

36 Scopus citations
Original languageEnglish (US)
Article numberg7809
JournalBMJ (Online)
StatePublished - Jan 13 2015

ASJC Scopus subject areas

  • General Medicine

Cite this